Skip to main content

Rezolute Inc (RZLT) Stock

Rezolute Inc Stock Details, Movements and Public Alerts

Stock Details

Rezolute Inc (RZLT), a prominent company in the healthcare sector within the biotechnology industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $1.80. Over the past 52 weeks, it has ranged between $1.07 and $11.46. This places the current price at 15.7% of its 52-week high and 68.2% above its 52-week low. Recent trading volume was recorded at 35,205,587. The 14-day Relative Strength Index (RSI) stands at 23.09, suggesting oversold conditions. The stock is currently trading below its 50-day moving average of $9.14 by 80.31%. Similarly, it is below its 200-day moving average of $6.04 by 70.20%. The MACD histogram is -0.81, indicating bearish momentum (MACD Line: -1.00, Signal Line: -0.19). There is currently 1 active alert set for RZLT by users.

52-Week Range

$11.46 - $1.07

-84.29% from high · +68.22% from low

Avg Daily Volume

9,695,414

20-day average

100-day avg: 2,955,082

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

N/A

Price to Book

6.90

EV/EBITDA

-0.01

EPS (TTM)

-$0.12

Beta

0.22

Less volatile than market

How is RZLT valued relative to its earnings and growth?
Valuation data is not available for this stock.
What is RZLT's risk profile compared to the market?
With a beta of 0.22, Rezolute Inc is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 6.90 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

0.00%

Operating Margin

0.00%

EBITDA

$-82,739,000

Return on Equity

-59.20%

Return on Assets

-36.70%

Revenue Growth (YoY)

0.00%

Earnings Growth (YoY)

0.00%

How profitable and efficient is RZLT's business model?
Profitability metrics are not available for this stock.
What are RZLT's recent growth trends?
Growth data is not available for this stock.

Company Size & Market

Market Cap

$129.8M

Revenue (TTM)

$0

Revenue/Share (TTM)

$0.00

Shares Outstanding

92.73M

Book Value/Share

$1.62

Asset Type

Common Stock

What is RZLT's market capitalization and position?
Rezolute Inc has a market capitalization of $129.8M, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 92.73M shares outstanding, the company's ownership is relatively concentrated. As a participant in the BIOTECHNOLOGY industry, it competes with other firms in this sector.
How does RZLT's price compare to its book value?
Rezolute Inc's book value per share is $1.62, while the current stock price is $1.80, resulting in a price-to-book (P/B) ratio of 1.11. This reasonable premium to book value suggests the market values the company's earnings power and intangible assets appropriately. Most profitable companies trade between 1-3x book value. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$12.00

566.67% upside potential

Analyst Recommendations

Strong Buy

2

Buy

8

Hold

0

Sell

0

Strong Sell

0

How reliable are analyst predictions for RZLT?
10 analysts cover RZLT with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $12.00 implies 566.7% upside, but targets are often adjusted to follow price moves rather than predict them.
What is the Wall Street consensus on RZLT?
Current analyst recommendations:2 Strong Buy, 8 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Dec 13, 2025, 08:47 AM

Technical Indicators

RSI (14-day)

23.09

Oversold

50-Day Moving Average

$9.14

-80.31% below MA-50

200-Day Moving Average

$6.04

-70.20% below MA-200

MACD Line

-1.00

MACD Signal

-0.19

MACD Histogram

-0.81

Bearish

What does RZLT's RSI value tell investors?
The RSI (Relative Strength Index) for RZLT is currently 23.09, indicating the stock is in oversold territory (below 30). This indicates heavy selling pressure that may have pushed the price too low too fast. Oversold readings can present buying opportunities, but stocks can remain oversold in strong downtrends. Look for RSI to rise above 30 as a potential recovery signal. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
How should traders interpret RZLT's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.00 below the signal line at -0.19, with histogram at -0.81. This bearish crossover indicates downward pressure. The 50-day MA ($9.14) is above the 200-day MA ($6.04), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently below both MAs, confirming weakness.

Indicators last updated: Dec 13, 2025, 12:49 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
70
Created
Dec 11, 2025, 05:50 PM

Stay Ahead of the Market with Rezolute Inc Alerts

Set up price alerts for Rezolute Inc and get notified instantly when the price hits your target. Never miss an important price movement again.